share_log

CVS Health | 424B3: Prospectus

CVS Health | 424B3: Prospectus

西維斯健康 | 424B3:募資說明書
美股SEC公告 ·  12/03 05:21

Moomoo AI 已提取核心訊息

On December 3, 2024, CVS Health announced an offering of Fixed-to-Fixed Rate Series A and B Junior Subordinated Notes, maturing in 2055 and 2054, respectively. The Series A Notes will bear interest from the issuance date to 2030, and the Series B Notes to 2034, with rates reset based on the Five-year U.S. Treasury Rate plus a spread.CVS Health may defer interest payments for up to 10 years, with deferred interest accruing additional interest. The notes are unsecured and subordinated to senior indebtedness, with no established trading market. Proceeds will be used for tender offers and general corporate purposes.The offering is not conditioned on the tender offers' completion. Settlement is expected in December 2024, with delivery through The Depository Trust Company. The notes involve certain risks, including subordination to senior debt and potential interest deferral.
On December 3, 2024, CVS Health announced an offering of Fixed-to-Fixed Rate Series A and B Junior Subordinated Notes, maturing in 2055 and 2054, respectively. The Series A Notes will bear interest from the issuance date to 2030, and the Series B Notes to 2034, with rates reset based on the Five-year U.S. Treasury Rate plus a spread.CVS Health may defer interest payments for up to 10 years, with deferred interest accruing additional interest. The notes are unsecured and subordinated to senior indebtedness, with no established trading market. Proceeds will be used for tender offers and general corporate purposes.The offering is not conditioned on the tender offers' completion. Settlement is expected in December 2024, with delivery through The Depository Trust Company. The notes involve certain risks, including subordination to senior debt and potential interest deferral.
2024年12月3日,CVS Health宣佈發行固定利率A系列和b系列初級次級票據,分別於2055年和2054年到期。A系列票據將從發行之日起計息至2030年,b系列票據將從發行之日起計息至2034年,利率將根據五年期美國國債利率加上利差進行重置。CVS Health最多可以將利息支付推遲10年,遞延利息應計額外利息。這些票據是無抵押的,從屬於優先債務,沒有成熟的交易市場。所得款項將用於要約和一般公司用途。此次發行不以投標要約的完成爲條件。預計將在2024年12月達成和解,並通過存託信託公司交付。這些票據涉及某些風險,包括優先債務的附屬權和潛在的延期利息。
2024年12月3日,CVS Health宣佈發行固定利率A系列和b系列初級次級票據,分別於2055年和2054年到期。A系列票據將從發行之日起計息至2030年,b系列票據將從發行之日起計息至2034年,利率將根據五年期美國國債利率加上利差進行重置。CVS Health最多可以將利息支付推遲10年,遞延利息應計額外利息。這些票據是無抵押的,從屬於優先債務,沒有成熟的交易市場。所得款項將用於要約和一般公司用途。此次發行不以投標要約的完成爲條件。預計將在2024年12月達成和解,並通過存託信託公司交付。這些票據涉及某些風險,包括優先債務的附屬權和潛在的延期利息。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息